CAMV
Concord Asset Management (Virginia)’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,329
| Closed | -$862K | – | 131 |
|
|
2024
Q4 | $862K | Buy |
9,329
+6,273
| +205% | +$579K | 0.19% | 86 |
|
|
2024
Q3 | $256K | Buy |
3,056
+111
| +4% | +$9.31K | 0.06% | 120 |
|
|
2024
Q2 | $202K | Sell |
2,945
-16,031
| -84% | -$1.1M | 0.05% | 130 |
|
|
2024
Q1 | $1.39M | Buy |
18,976
+2,868
| +18% | +$210K | 0.37% | 63 |
|
|
2023
Q4 | $1.3M | Buy |
16,108
+6,365
| +65% | +$516K | 0.38% | 59 |
|
|
2023
Q3 | $730K | Buy |
9,743
+2,443
| +33% | +$183K | 0.24% | 67 |
|
|
2023
Q2 | $563K | Buy |
7,300
+1,541
| +27% | +$119K | 0.2% | 63 |
|
|
2023
Q1 | $478K | Buy |
+5,759
| New | +$478K | 0.2% | 59 |
|